Artio closes $28M as it scales to save lives; latest funding brings Prairie Village startup’s investments to $74M
June 16, 2022 | Startland News Staff
Another hefty funding round for Artio Medical is expected to launch the startup’s commercial sales team in the U.S. and continue development of its best-in-class product pipeline, said founder Nicholas Franano.
Artio, a medical device company developing innovative products for the peripheral vascular, neurovascular, and cardiology markets, on Thursday announced the closing of $28 million in oversubscribed Series A2 and Series A3 financing, bringing the total amount raised to date to $74 million.
Funds will be used to support U.S. commercialization efforts for the recently cleared Solus Gold Embolization Device and to accelerate the development of Artio’s broad portfolio of products, including expanding the company’s engineering and manufacturing capabilities, Franano said in a press release.
Click here to read more about Artio’s $12 million funding infusion in 2021.
“We would like to thank our existing investors for their continued strong support and also welcome a new group of investors to Artio,” said Joseph McConnell, vice president of finance and business operations at Artio.
“We have the opportunity to do something really special here, to bring a new generation of medical devices to market with the potential to save lives, reduce disability, and improve the quality of life for millions of people,” McConnell continued. “This new capital will help Artio expand our team and scale our operations to deliver on that mission.”
Artio is currently developing ten products for the peripheral vascular market, including the Solus Gold and Solus Flex Embolization Devices for peripheral vessel occlusion and the Amplifi Vein Dilation System which is designed to prepare hemodialysis patients for successful arteriovenous fistula vascular access site creation.
Artio is also currently developing four products for the neurovascular market, including the Endura Embolization System comprising a detachable balloon and coils for the treatment of saccular brain aneurysms.
Click here to learn more about Artio’s portfolio of products.

2022 Startups to Watch
stats here
Related Posts on Startland News
Quick studies: These Kansans just left their college careers for $500K (and a crash course in startups)
When a friend encouraged Aditya Joshi and Varun Verma to apply for the Y Combinator accelerator program, the Wichita natives didn’t expect to land an interview, they shared — much less get accepted. “Truly, all we had was this idea and a couple of months under our belt of just talking to different folks,” Joshi…
Siblings spin family pet into family business, capitalizing on alpaca’s plush potential
One Wyandotte County family’s trip to a local fair inspired their interest in alpacas, but it wasn’t until they brought one of the animals home as a pet that they realized the business opportunities they’d unleashed. “That’s where the idea started of — ‘Hey, we can actually make this an Alpaca clothing company and reduce…
Black Drip releases canned cold brew as KC coffee maker leans into creative blends
A new cold brew version from Charon Thompson’s popular Kansas City coffee brand drips with strength, the co-founder said, teasing its arrival on the market just as the metro begins to heat up for the spring. “I can’t sell hot coffee when it’s like 92 degrees,” said Thompson, recalling an experience during a Black Drip…
GOP lawmaker from Missouri takes over chair of Small Business Caucus in DC
Entrepreneurship and small businesses are the lifeblood of America, said Mark Alford, pledging to use his new leadership role within the Small Business Caucus to help fellow congressmen workshop and pursue policies that will “ensure the safety and prosperity of Main Street America.” U.S. Rep. Alford, R-Missouri, publicly took over the co-chair role of the…

